An official website of the United States government
A .mil website belongs to an official U.S. Department of Defense organization in the United States.
A lock (lock ) or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.










 
181 - 192 of 9379 results
Thumbnails List
Pensacola, FL
A certificate of accreditation from the Undersea and Hyperbaric Medical Society (UHMS) is showcased on Barrancas Beach, located on Naval Air Station Pensacola, after the hyperbaric chamber at the Naval Aerospace Medical Institute (NAMI) was awarded a Level-1 "With Distinction" accreditation, Nov. 21. The certificate signifies the highest levels of proficiency offered by the UHMS and is a mark of excellence awarded to facilities that continually operate and maintain the highest levels of readiness. The divers knife/tool, long held as a symbol of military divers around the world, represents an operationally ready team equipped with the resolve to protect and go into harms way if ever needed. With five detachments, 12 training centers, and facilities in over 60 locations across the United States, NMOTC provides high impact individual medical training for the Navy, other U.S. armed forces, and allied nations around the globe. (U.S. Navy photo by Mass Communication Specialist 1st Class Russell Lindsey SW/AW)
Pensacola, FL
The hyperbaric chamber stands located at the Naval Aerospace Medical Institute (NAMI) stands at the ready after being awarded a Level-1 "With Distinction" accreditation from the Undersea and Hyperbaric Medical Society (UHMS), Nov. 21. With five detachments, 12 training centers, and facilities in over 60 locations across the United States, NMOTC provides high impact individual medical training for the Navy, other U.S. armed forces, and allied nations around the globe. (U.S. Navy photo by Mass Communication Specialist 1st Class Russell Lindsey SW/AW)
CAMP LEMONNIER, DJIBOUTI
CAMP LEMONNIER, Djibouti (Sept. 23, 2025) Members of Naval Medical Research Unit (NAMRU) EURAFCENT pose for a photo aboard Camp Lemonnier, Djibouti, where NAMRU EURAFCENT researchers work to improve the prevention of infectious diseases, such as traveler’s diarrhea, that can impede U.S. service members’ health and mission readiness. NAMRU EURAFCENT, part of Navy Medicine Research & Development, conducts research, surveillance and studies of vaccines, therapeutic agents, diagnostic assays and vector control measures in the EUCOM, AFRICOM and CENTCOM Areas of Responsibility to better prevent and treat infectious diseases in support of Navy, Marine Corps and joint U.S. warfighter health, readiness and lethality. For 250 years, Navy Medicine, represented by more than 44,000 highly-trained military and civilian healthcare professionals, has delivered quality healthcare and enduring expeditionary medical support to the warfighter on, below, and above the sea and ashore. (U.S. Navy photo by Cmdr. Mark Simons/Released)
YOKOSUKA, JAPAN
YOKOSUKA, Japan (Dec. 8, 2025) — Hospitalman Apprentice Skylar L. Foote, assigned to U.S. Naval Hospital Yokosuka, poses outside the hospital where she received the Navy and Marine Corps Achievement Medal during an awards ceremony. Foote was recognized for her life-saving response aboard a commercial flight in July, where she assessed, monitored, and coordinated care for a passenger experiencing medical distress until the aircraft landed safely. (U.S. Navy photo by Daniel Taylor/USNMRTC Yokosuka Public Affairs)
YOKOSUKA, JAPAN
YOKOSUKA, Japan (Nov. 19, 2025) — Hospitalman Apprentice Skylar L. Foote, left, assigned to U.S. Naval Hospital Yokosuka, receives the Navy and Marine Corps Achievement Medal from Capt. Donavon YapShing, executive officer of U.S. Navy Medicine Readiness and Training Command Yokosuka and deputy director of U.S. Naval Hospital Yokosuka, during an awards ceremony. Foote was recognized for her life-saving response aboard a commercial flight in July, where she assessed, monitored, and coordinated care for a passenger experiencing medical distress until the aircraft landed safely. (U.S. Navy photo by Daniel Taylor/USNMRTC Yokosuka Public Affairs)
San Antonio, TX
JOINT BASE SAN ANTONIO-FORT SAM HOUSTON (Dec. 8, 2025) Research scientist Phylisia Dimas, assigned to Naval Medical Research Unit (NAMRU) San Antonio, speaks with Dr. Jeremy Pamplin, program manager, Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), on the Nikon Eclipse Ti2 confocal microscope utilized for the assessment of DARPA’s Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) program’s novel synthetic blood product at the Battlefield Health & Trauma Research Institute. The FSHARP program works to develop a deployable, shelf-stable, universal whole blood substitute as a hemorrhage countermeasure to sustain injured warfighters in austere, pre-hospital settings. NAMRU San Antonio serves as the Independent Validation & Verification partner for the FSHARP program to perform laboratory testing for safety and efficacy. The confocal microscope can capture images of fixed and live tissue using magnifications from 4X to 60X at four different fluorescent filters. Other features include a controlled environmental chamber to perform live cell imaging, automation and software full of endless imaging and analysis tools. NAMRU San Antonio, part of Navy Medicine Research & Development, works alongside research partners in the civilian sphere, academia, industry, and other government agencies to drive support of the Department of War’s objectives for a lethal fighting force and ensures U.S. service members have access to the latest scientific advances. NAMRU San Antonio conducts gap-driven combat casualty care, craniofacial, and directed energy research in support of Navy, Marine Corps and joint U.S. warfighter health readiness and lethality while engaged in routine and expeditionary operations. (U.S. Navy photo by Burrell Parmer/Released)
San Antonio, TX
JOINT BASE SAN ANTONIO-FORT SAM HOUSTON (Dec. 8, 2025) Research scientist Juan Curbelo (left) and research immunologist Dr. Dao Ho assigned to Naval Medical Research Unit (NAMRU) San Antonio’s Combat Casualty Care and Operational Medicine directorate, explain the cell-based, in vitro platforms used to test the safety and efficacy of the Defense Advanced Research Projects Agency’s (DARPA) Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) program’s novel synthetic blood product to Dr. Jeremy Pamplin, program manager, DARPA’s Biological Technologies Office at the Battlefield Health & Trauma Research Institute. The FSHARP program works to develop a deployable, shelf-stable, universal whole blood substitute as a hemorrhage countermeasure to sustain injured warfighters in austere, pre-hospital settings. NAMRU San Antonio serves as the Independent Validation & Verification partner for the FSHARP program to perform laboratory testing for safety and efficacy. The platforms used by NAMRU San Antonio incorporate both 2D and 3D formats, thus allowing the research scientists to assess endothelial barrier function in models that mimic the form and function of tubular blood vessels, which is translational to human physiology. NAMRU San Antonio, part of Navy Medicine Research & Development, works alongside research partners in the civilian sphere, academia, industry, and other government agencies to drive support of the Department of War’s objectives for a lethal fighting force and ensures U.S. service members have access to the latest scientific advances. NAMRU San Antonio conducts gap-driven combat casualty care, craniofacial, and directed energy research in support of Navy, Marine Corps and joint U.S. warfighter health readiness and lethality while engaged in routine and expeditionary operations. (U.S. Navy photo by Burrell Parmer/Released)
San Antonio, TX
JOINT BASE SAN ANTONIO-FORT SAM HOUSTON (Dec. 8, 2025) Dr. Jeremy Pamplin, (center) program manager, Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), examines the method by which research scientists at Naval Medical Research Unit (NAMRU) San Antonio assess a wide range of inflammatory biomarkers in biological samples in support of DARPA’s Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) program at the Battlefield Health & Trauma Research Institute. NAMRU San Antonio serves as the Independent Validation & Verification partner for the FSHARP program to perform laboratory testing for safety and efficacy. The FSHARP program works to develop a deployable, shelf-stable, universal whole blood substitute as a hemorrhage countermeasure to sustain injured warfighters in austere, pre-hospital settings. NAMRU San Antonio, part of Navy Medicine Research & Development, works alongside research partners in the civilian sphere, academia, industry, and other government agencies to drive support of the Department of War’s objectives for a lethal fighting force and ensures U.S. service members have access to the latest scientific advances. NAMRU San Antonio conducts gap-driven combat casualty care, craniofacial, and directed energy research in support of Navy, Marine Corps and joint U.S. warfighter health readiness and lethality while engaged in routine and expeditionary operations. (U.S. Navy photo by Burrell Parmer/Released)
San Antonio, TX
JOINT BASE SAN ANTONIO-FORT SAM HOUSTON (Dec. 8, 2025) Dr. Jeremy Pamplin, (center) program manager, Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), views a novel synthetic blood product that is being developed under DARPA’s Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) program at the Battlefield Health & Trauma Research Institute. Naval Medical Research Unit (NAMRU) San Antonio serves as the Independent Validation & Verification partner for the FSHARP program to perform laboratory testing for safety and efficacy. The FSHARP program works to develop a deployable, shelf-stable, universal whole blood substitute as a hemorrhage countermeasure to sustain injured warfighters in austere, pre-hospital settings. NAMRU San Antonio, part of Navy Medicine Research & Development, works alongside research partners in the civilian sphere, academia, industry, and other government agencies to drive support of the Department of War’s objectives for a lethal fighting force and ensures U.S. service members have access to the latest scientific advances. NAMRU San Antonio conducts gap-driven combat casualty care, craniofacial, and directed energy research in support of Navy, Marine Corps and joint U.S. warfighter health readiness and lethality while engaged in routine and expeditionary operations. (U.S. Navy photo by Burrell Parmer/Released)
San Antonio, TX
JOINT BASE SAN ANTONIO-FORT SAM HOUSTON (Dec. 8, 2025) Dr. Jeremy Pamplin, (center) program manager, Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), is briefed by research immunologist Dr. Dao Ho (right) and research scientist Phylisia Dimas, assigned to Naval Medical Research Unit (NAMRU) San Antonio on the specific methods by which NAMRU-SA assesses the viability and proliferation of living cells for DARPA’s Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) program at the Battlefield Health & Trauma Research Institute. The FSHARP program works to develop a deployable, shelf-stable, universal whole blood substitute as a hemorrhage countermeasure to sustain injured warfighters in austere, pre-hospital settings. NAMRU San Antonio, part of Navy Medicine Research & Development, works alongside research partners in the civilian sphere, academia, industry, and other government agencies to drive support of the Department of War’s objectives for a lethal fighting force and ensures U.S. service members have access to the latest scientific advances. NAMRU San Antonio conducts gap-driven combat casualty care, craniofacial, and directed energy research in support of Navy, Marine Corps and joint U.S. warfighter health readiness and lethality while engaged in routine and expeditionary operations. (U.S. Navy photo by Burrell Parmer/Released)
San Antonio, TX
JOINT BASE SAN ANTONIO-FORT SAM HOUSTON (Dec. 8, 2025) Dr. Jeremy Pamplin, (center) program manager, Biological Technologies Office, Defense Advanced Research Projects Agency (DARPA), visited with leadership and research scientists assigned to Naval Medical Research Unit (NAMRU) San Antonio at the Battlefield Health & Trauma Research Institute. During his visit, Pamplin, a retired U.S. Army Colonel, toured laboratories where research scientists, within the Combat Casualty Care and Operational Medicine directorate, perform experiments that support the Independent Validation & Verification effort for DARPA’s Fieldable Solutions for Hemorrhage with bio-Artificial Resuscitation Products (FSHARP) program. The FSHARP program works to develop a deployable, shelf-stable, universal whole blood substitute as a hemorrhage countermeasure to sustain injured warfighters in austere, pre-hospital settings. NAMRU San Antonio, part of Navy Medicine Research & Development, works alongside research partners in the civilian sphere, academia, industry, and other government agencies to drive support of the Department of War’s objectives for a lethal fighting force and ensures U.S. service members have access to the latest scientific advances. NAMRU San Antonio conducts gap-driven combat casualty care, craniofacial, and directed energy research in support of Navy, Marine Corps and joint U.S. warfighter health readiness and lethality while engaged in routine and expeditionary operations. (U.S. Navy photo by Burrell Parmer/Released)
Camp Lejeune, NC
Registered Nurse Angela Williams, center, is pictured with her fellow Inpatient Mental Health employees at Naval Medical Center Camp Lejeune on Nov. 24, 2025. Williams was awarded the DAISY Award, a national recognition that honors nurses for their lasting impact on their patients. Williams was nominated by a patient's family for her "deeply human approach to care." NMCCL has provided more than 80 years of dedicated, passionate care for warfighters and beneficiaries at Marine Corps Base Camp Lejeune.
BUMED Seal


Bureau of Medicine and Surgery
7700 Arlington Blvd. Ste. 5113 Falls Church, VA 22042-5113
This is an official U.S. Navy website
This is a Department of Defense (DoD) Internet computer system.

General Navy Medical Inquiries (to Bureau of Medicine and Surgery): usn.ncr.bumedfchva.list.bumed---pao@health.mil
 


Charlie Mike Flags
 

Facebook Icon   Twitter  Instagram  YouTube  LinkedIn  Flickr Internet Archive
Safe Helpline
Veterans Crisis Line
Northern Command: Dial 988 then Press 1
Pacific Command: Call +1 844-702-5493 (off base) or DSN 988 (on base)
European Command: Call +1 844-702-5495 (off base) or DSN 988 (on base)
Central Command: Call +1 855-422-7719 (off base) or DSN 988 (on base)
African Command: Call +1 888-482-6054 (off base) or DSN 988 (on base)
Southern Command: Call +1 866-989-9599 (off base) or DSN 988 (on base)
Guidance-Card-Icon Dept-Exclusive-Card-Icon